← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2001Last known activity
Aug 4, 2025
Timeline
1990s
- Jan 1, 1990
BioGaia AB— Founded
2020s
- Jul 2, 2021
Metabogen— Acquired
Drugs by trial phase (14 distinct, 49 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (49)
- NCT07190859Lead sponsorN/AAug 4, 2025
- NCT06462651Lead sponsorN/AOct 31, 2024
- NCT06026228CollaboratorN/AJan 31, 2024
- NCT05512234Lead sponsorN/AJul 13, 2022
- NCT05512234Study directorN/AJul 13, 2022
- NCT05548361CollaboratorN/AApr 1, 2022
- NCT05118919Lead sponsorPhase 1/Phase 2Nov 30, 2021
- NCT05133076Study directorPhase 2Nov 30, 2021
- NCT05133076Lead sponsorPhase 2Nov 30, 2021
- NCT04767711CollaboratorN/AMay 31, 2021
- NCT04847960CollaboratorN/AMar 22, 2021
- NCT04734886CollaboratorN/ANov 27, 2020
- NCT04598633CollaboratorN/ANov 24, 2020
- NCT04577625Lead sponsorN/ANov 5, 2020
- NCT04606186CollaboratorN/AOct 19, 2020
Details
- Founded
- Stockholm, SE Jan 1, 1990
- Last known activity
- Aug 4, 2025